Patterns of Lymph Node Metastasis and Optimal Surgical Strategy in Small (≤20 mm) Gastroenteropancreatic Neuroendocrine Tumors

被引:4
|
作者
Cai, Yibo [1 ]
Liu, Zhuo [1 ]
Jiang, Lai [1 ]
Ma, Dening [1 ]
Zhou, Zhenyuan [1 ]
Ju, Haixing [1 ]
Zhu, Yuping [1 ]
机构
[1] Chinese Acad Sci, Canc Hosp, Zhejiang Canc Hosp,Univ Chinese Acad Sci, Inst Basic Med & Canc IBMC,Dept Colerectal Surg, Hangzhou, Peoples R China
来源
关键词
gastroenteropancreatic neuroendocrine tumors; small tumor size; lymph node metastatic patterns; surgical strategy; SEER database; CONSENSUS GUIDELINES UPDATE; MANAGEMENT; CARCINOIDS; SURVIVAL; PROGNOSIS; NEOPLASMS; SURGERY; SIZE;
D O I
10.3389/fendo.2022.871830
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundRegional lymph node metastasis (LNM) is crucial for planning additional lymphadenectomy, and is directly correlated with poor prognosis in gastroenteropancreatic neuroendocrine tumors (GEP-NETs). However, the patterns of LNM for small (<= 20 mm) GEP-NETs remain unclear. This population-based study aimed at evaluating LNM patterns and identifying optimal surgical strategies from the standpoint of lymph node dissemination. MethodsThis retrospective cohort study retrieved data from the Surveillance, Epidemiology, and End Results (SEER) 18 registries database for 17,308 patients diagnosed as having localized well-differentiated GEP-NETs <= 20 mm between January 1, 2004, and December 31, 2017. The patterns of LNM were characterized in 6,622 patients who underwent extended resection for adequate lymph node harvest. ResultsOf 6,622 patients with localized small GEP-NETs in the current study, 2,380 (36%) presented with LNM after regional lymphadenectomy. Nodal involvement was observed in approximately 7.4%, 49.1%, 13.6%, 53.7%, 13.8%, 7.8%, and 15.4% of gastric (g-), small intestinal (si-), appendiceal (a-), colonic (c-), rectal (r-), non-functional pancreatic (nfp-), and functional pancreatic (fp-) NETs <= 20 mm. Patients with younger age, larger tumor size, and muscularis invasion were more likely to present with LNM. Additional lymphadenectomy conferred a significant survival advantage in NETs (<= 10 mm: HR, 0.47; 95% CI, 0.33-0.66; p < 0.001; 11-20 mm: HR, 0.54; 95% CI, 0.34-0.85; p = 0.008) and fp-NETs <= 20 mm (HR, 0.08; 95% CI, 0.02-0.36; p = 0.001), as well as g-NETs (HR, 0.39; 95% CI, 0.16-0.96; p = 0.041) and c-NETs of 11-20 mm (HR, 0.07; 95% CI, 0.01-0.48; p = 0.007). Survival benefits of additional lymphadenectomy were not found in a-NETs, r-NETs, and nfp-NETs with a small size. ConclusionsGiven the increased risk for nodal metastasis, primary tumor resection with regional lymphadenectomy is a potential optimal surgical strategy for si-NETs and fp-NETs <= 20 mm, as well as g-NETs and c-NETs of 11-20 mm. Local resection is an appropriate and reliable surgical approach for a-NETs, r-NETs, and nfp-NETs <= 20 mm.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Lymph Node Metastasis in the Prognosis of Gastroenteropancreatic Neuroendocrine Tumors
    Martin, Jacob A.
    Warner, Richard R. P.
    Aronson, Anne
    Wisnivesky, Juan P.
    Kim, Michelle Kang
    [J]. PANCREAS, 2017, 46 (09) : 1214 - 1218
  • [2] GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS: SIZE AS AN INDICATOR OF LYMPH NODE AND DISTANT METASTASIS AND SURVIVAL
    Bloom-Feshbach, Kimberly
    Martin, Jacob A.
    Yoon, Jiyoon
    Wisnivesky, Juan
    Kim, Michelle K.
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S669 - S669
  • [3] Examination of Lymph Node Status in Gastroenteropancreatic Neuroendocrine Tumors
    Carrillo-Polanco, Luis
    Bonneau, Peter N.
    Hartley, Christopher
    Hagen, Catherine
    [J]. MODERN PATHOLOGY, 2017, 30 : 163A - 164A
  • [4] Examination of Lymph Node Status in Gastroenteropancreatic Neuroendocrine Tumors
    Carrillo-Polanco, Luis
    Bonneau, Peter N.
    Hartley, Christopher
    Hagen, Catherine
    [J]. LABORATORY INVESTIGATION, 2017, 97 : 163A - 164A
  • [5] Lymph node metastases in the prognosis of gastroenteropancreatic neuroendocrine tumors.
    Martin, Jacob Andrew
    Wisnivesky, Juan P.
    Kim, Michelle Kang
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [6] DUODENAL NEUROENDOCRINE TUMORS AND LYMPH NODE METASTASIS
    Roth, David M.
    Gillespie, Theresa W.
    Patel, Vaishali
    Merchant, Ambreen A.
    Chawla, Saurabh
    Keilin, Steven
    Cai, Qiang
    Willingham, Field F.
    [J]. GASTROINTESTINAL ENDOSCOPY, 2021, 93 (06) : AB339 - AB340
  • [7] Clinicopathological features and lymph node and distant metastasis patterns in patients with gastroenteropancreatic mixed neuroendocrine-non-neuroendocrine neoplasm
    Zhang, Panpan
    Li, Zhongwu
    Li, Jie
    Li, Jian
    Zhang, Xiaotian
    Lu, Zhihao
    Sun, Yu
    Li, Yan
    Zhou, Jun
    Wang, Xicheng
    Peng, Zhi
    Shen, Lin
    Lu, Ming
    [J]. CANCER MEDICINE, 2021, 10 (14): : 4855 - 4863
  • [8] LYMPH NODE METASTASIS WITH SMALL DUODENAL NEUROENDOCRINE TUMORS: IMPLICATIONS FOR ENDOSCOPIC MANAGEMENT
    Patel, Maya
    Das, Rishi
    Liu, Yuan
    Roth, David
    Patel, Vaishali
    Orr, Jordan
    Chawla, Saurabh
    Keilin, Steven
    Willingham, Field
    [J]. GASTROINTESTINAL ENDOSCOPY, 2024, 99 (06) : AB1106 - AB1106
  • [9] Risk factors of lymph node metastasis in rectal neuroendocrine tumors
    Donghong Liang
    Zhennan Niu
    Xiaofang Sun
    Changjuan Meng
    Zhuang Liu
    [J]. Oncology and Translational Medicine, 2022, 8 (04) : 186 - 190
  • [10] Significance of lymph node metastasis in pancreatic neuroendocrine tumors.
    Taki, Katsunobu
    Hashimoto, Daisuke
    Ozaki, Nobuyuki
    Tomiyasu, Shinjiro
    Inoue, Risa
    Yamamura, Kensuke
    Kitano, Yuuki
    Arima, Kota
    Kaida, Takayoshi
    Higashi, Takaaki
    Imai, Katsunori
    Chikamoto, Akira
    Beppu, Toru
    Takamori, Hiroshi
    Hirota, Masahiko
    Baba, Hideo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)